This provider's $27.1M in total Medicare payments ranks in the 99th percentile of Ophthalmology providers nationally.
Medicare payments to this provider grew 133% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $446.42 | $212.56 | 2.10x | $233.86 | $1.4M | 6.8K | 13 |
| 2015 | $467.56 | $226.92 | 2.06x | $240.64 | $1.9M | 8.6K | 13 |
| 2016 | $423.30 | $194.68 | 2.17x | $228.62 | $2.2M | 11.4K | 16 |
| 2017 | $442.34 | $206.60 | 2.14x | $235.74 | $2.8M | 13.8K | 22 |
| 2018 | $457.58 | $216.06 | 2.12x | $241.52 | $2.9M | 13.4K | 18 |
| 2019 | $480.33 | $224.95 | 2.14x | $255.38 | $3.1M | 13.7K | 15 |
| 2020 | $546.87 | $253.60 | 2.16x | $293.27 | $3.1M | 12.1K | 13 |
| 2021 | $559.54 | $256.75 | 2.18x | $302.79 | $3.2M | 12.4K | 13 |
| 2022 | $563.18 | $246.91 | 2.28x | $316.27 | $3.1M | 12.6K | 12 |
| 2023 | $389.89 | $165.66 | 2.35x | $224.23 | $3.4M | 20.3K | 14 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | 21.5K | $15.9M | $736.11 | 1.70x |
| J2778 | Injection, ranibizumab, 0.1 mg | 24.8K | $6.8M | $274.50 | 1.82x |
| 67028 | Injection of drug into eye | 16.5K | $1.4M | $85.08 | 7.97x |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 6.5K | $555.7K | $85.77 | 2.33x |
| 92134 | Imaging of retina | 15.6K | $475.8K | $30.51 | 3.28x |
| 92250 | Photography of the retina | 10.0K | $370.2K | $36.87 | 4.07x |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 3.6K | $226.9K | $63.17 | 2.54x |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 2.0K | $226.3K | $112.53 | 1.97x |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 8.0K | $214.4K | $26.87 | 1.58x |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 2.4K | $181.1K | $75.91 | 3.29x |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 1.1K | $177.6K | $157.61 | 1.74x |
| J3590 | Unclassified biologics | 1.3K | $149.5K | $115.79 | 3.19x |
| J9035 | Injection, bevacizumab, 10 mg | 1.9K | $108.1K | $56.47 | 1.80x |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 525 | $90.4K | $172.29 | 2.55x |
| 67228 | Laser destruction of leaking retinal blood vessels, 1 or more sessions | 218 | $83.0K | $380.61 | 5.28x |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 553 | $38.2K | $69.07 | 2.94x |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | 536 | $33.1K | $61.79 | 2.43x |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | 333 | $25.6K | $77.01 | 2.59x |
| 67210 | Laser destruction of retinal growth, 1 or more sessions | 57 | $22.6K | $396.08 | 3.79x |
| 67041 | Removal of membrane from the retina | 24 | $20.0K | $833.53 | 6.00x |
This provider submits charges 2.18 times higher than what Medicare actually pays.
A markup ratio of 2.18x means for every $100 Medicare pays, this provider initially charges $218. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Ophthalmology providers in NC for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Shil Patel, M.D. | New Bern, NC | $63.1M | ✓ Clear |
| James Pate, M.D. | Raleigh, NC | $44.5M | ✓ Clear |
| Justin Brown, M.D. | Charlotte, NC | $43.5M | ✓ Clear |
| Nitin Gupta, M.D., M.P.H. | Raleigh, NC | $42.0M | ✓ Clear |
| Igor Westra, MD | Wilmington, NC | $40.5M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data